Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Inventory (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Inventory for 3 consecutive years, with $2.9 million as the latest value for Q4 2025.

  • Quarterly Inventory changed N/A to $2.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 million through Dec 2025, changed N/A year-over-year, with the annual reading at $2.9 million for FY2025, N/A changed from the prior year.
  • Inventory for Q4 2025 was $2.9 million at LENZ Therapeutics, up from $949000.0 in the prior quarter.
  • The five-year high for Inventory was $2.9 million in Q4 2025, with the low at $39000.0 in Q2 2023.
  • Average Inventory over 3 years is $1.8 million, with a median of $1.9 million recorded in 2022.
  • Peak annual rise in Inventory hit 23.31% in 2023, while the deepest fall reached 97.68% in 2023.
  • Over 3 years, Inventory stood at $2.5 million in 2022, then plummeted by 98.43% to $39000.0 in 2023, then surged by 7428.21% to $2.9 million in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $2.9 million, $949000.0, and $39000.0 for Q4 2025, Q3 2025, and Q2 2023 respectively.